RecruitingNot ApplicableNCT05524428
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
Sponsor
Massachusetts General Hospital
Enrollment
2 participants
Start Date
Mar 24, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Staff members at partnering sites (see locations) who are administrative leaders, population health managers, data analysts, quality improvement staff, nurses, nurse managers, practice managers, medical assistants, and providers.
- Staff members at partnering sites ages 18+.
Exclusion Criteria1
- Staff members that are not involved in CRC screening practices at CHCs.
Interventions
BEHAVIORALImplementation Science Strategy
The investigators will be conducting focus groups and identifying barriers and facilitators, and the investigators will be matching identified barriers and facilitators to implementation strategies at the patient, provider, and system level which the investigators will be testing using rapid-cycle methods.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05524428
Related Trials
A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
NCT074697091 location
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
NCT071452557 locations
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NCT070850917 locations
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
NCT065633881 location
The AIDPRO-CRC Trial
NCT066450157 locations